Next |
home / stock / oncy / oncy message board
Subject | By | Source | When |
---|---|---|---|
Next stop $3.00 then $4.00 then its pretty | accipiterr | investorshub | 06/22/2023 3:45:38 PM |
Also Phase 1 Clinical trials for viral loaded | accipiterr | investorshub | 06/22/2023 3:24:46 PM |
$ONCY IS A PHASE 3 BIOTECH COMPANY WITH | accipiterr | investorshub | 06/22/2023 3:20:16 PM |
I am here. Here is a comment for | accipiterr | investorshub | 06/22/2023 3:08:51 PM |
NEWS -- Oncolytics Biotech's® Pelareorep Selected for Inclusion | Paulness | investorshub | 06/22/2023 1:39:57 PM |
$ONCY got some short data | Paulness | investorshub | 06/19/2023 12:28:06 AM |
$ONCY should we be shorting? | Selain7 | investorshub | 06/16/2023 10:48:24 PM |
$ONCY Anyone hear anything lately? Want to see this one go | Cobra Stock Sleuth | investorshub | 06/16/2023 2:49:59 AM |
$ONCY and the shorts continue | Paulness | investorshub | 06/15/2023 2:51:57 AM |
Bristol-Myers Squibb news coming !!!!!!!!!!!!!!! | Paulness | investorshub | 06/06/2023 12:41:58 AM |
NEWS -- Oncolytics Biotech Announces Updated Randomized Phase | Paulness | investorshub | 06/05/2023 12:55:31 PM |
what does this mean? | Paulness | investorshub | 06/04/2023 10:08:02 PM |
When is this gonna take off? | Paulness | investorshub | 06/04/2023 4:47:39 PM |
$ONCY what do you make of this data? | Paulness | investorshub | 06/04/2023 6:57:52 AM |
$ONCY and the shorts continue | Paulness | investorshub | 06/02/2023 11:42:19 PM |
what do you make of this data? | KngmAz | investorshub | 06/01/2023 7:37:14 PM |
The trading | tknuncle | investorshub | 05/31/2023 8:05:46 PM |
$ONCY MomentumIts trading | Paulness | investorshub | 05/31/2023 1:29:48 PM |
great news | Cobra Stock Sleuth | investorshub | 05/31/2023 8:34:33 AM |
$ONCY short squeeze signal | 1984ISHERE | investorshub | 05/28/2023 12:02:50 AM |
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...